接受化疗和特异性主动免疫治疗的播散性恶性黑色素瘤患者的肿瘤消退及生存情况 - Suppr

Suppr

超能文献

Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.

作者信息

Hedley D W, McElwain T J, Currie G A

出版信息

Eur J Cancer (1965). 1977 Oct;13(10):1169-73. doi: 10.1016/0014-2964(77)90017-2.

DOI:10.1016/0014-2964(77)90017-2

PMID:923614

Abstract

摘要

相似文献

Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.

Eur J Cancer (1965). 1977 Oct;13(10):1169-73. doi: 10.1016/0014-2964(77)90017-2.

Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.

Br J Cancer. 1976 Aug;34(2):174-9. doi: 10.1038/bjc.1976.140.

Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.

Surg Gynecol Obstet. 1978 Feb;146(2):230-2.

Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.

Recent Results Cancer Res. 1978;68:375-9. doi: 10.1007/978-3-642-81332-0_56.

Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment.

Recent Results Cancer Res. 1978;68:380-6. doi: 10.1007/978-3-642-81332-0_57.

Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.

Surgery. 1978 Jun;83(6):677-81.

Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.

Cancer Treat Rep. 1978 Jul;62(7):1085-7.

Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.

Cancer Treat Rep. 1976 Feb;60(2):177-82.

Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.

Br J Cancer. 1975 Feb;31(2):143-56. doi: 10.1038/bjc.1975.19.

Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma.

Recent Results Cancer Res. 1978;68:367-74. doi: 10.1007/978-3-642-81332-0_55.

引用本文的文献

Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.

Br J Cancer. 1978 Apr;37(4):491-6. doi: 10.1038/bjc.1978.76.

Combined modality therapy of malignant melanoma.

World J Surg. 1979 Jul 30;3(3):329-43. doi: 10.1007/BF01556586.

Chemotherapy of malignant melanoma.

World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584.

Cancer immunotherapy.

Can Med Assoc J. 1979 Feb 3;120(3):322-4, 329.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验